Efficacy of Metformin in the Treatment of Diabetes Mellitus Complicating Thalassemia Major

Auteur/ices

  • N Dhouib
  • Z Turki
  • F Mellouli
  • M Ouederni
  • S Yahiaoui
  • S Nagi
  • C Ben Slama
  • N Bejaoui

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Références

Farmaki K, Angelopoulous N, Anagnostopoulous G, Gotsis E, Rombopoulos G, Tolis G. Effect of enhanced iron chelation therapy on glucose metabolism in patients with ‚-thalassaemia major. Br J Haematol. 2006; 134: 438-444.

Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;16: 139-146.

Chern JP, Lin KH, Lu MY, Lin D, Lin KS, Chen JD, Fu CC. Abnormal glucose tolerance in transfusion-dependent beta thalassemic patients. Diabetes care. 2001; 24: 850-854.

Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs.2003; 63: 1879-1894.

Kosecki SM, Rodgers PT, Adams MB .Glycaemic monitoring in diabetics with sickle cell plus beta-thalassemia haemoglobinopathy. Ann Pharmacother.2005; 39: 1557-1560.

Téléchargements

Publiée

2010-02-18

Numéro

Rubrique

lettres a la redaction

Catégories